Omron (OTCMKTS:OMRNY) Downgraded to Strong Sell Rating by Zacks Research

Omron (OTCMKTS:OMRNY) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Thursday,Zacks.com reports.

Omron Stock Performance

OMRNY opened at $34.52 on Thursday. Omron has a twelve month low of $23.23 and a twelve month high of $40.76. The firm has a market capitalization of $6.79 billion, a PE ratio of 36.34, a PEG ratio of 0.44 and a beta of 1.15. The company has a current ratio of 2.11, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average price is $34.18 and its 200 day moving average price is $29.93.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC lifted its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 1.09% of the company’s stock.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.